Abstract
The interactions of the three sesquiterpene lactones (SLs) dihydrohelenalin acetate,
dihydrohelenalin methacrylate and helenalin isobutyrate from Arnica montana and of parthenolide from Tanacetum parthenium as well as of three ethanolic Arnica preparations with human blood proteins using different matrices, human serum albumin
(HSA), plasma and whole blood, were investigated. The extent of protein binding in
human plasma or to human albumin differed significantly between individual SLs (dihydrohelenalin
methacrylate < dihydrohelenalin acetate < helenalin isobutyrate << parthenolide),
e. g., 30 % to 50 % of the SLs were bound to plasma. On the whole, SLs in the ethanolic
preparations showed a lower degree of protein binding. Interestingly, although HSA
has a reactive thiol group at its cysteine-34 position which is prone to react with
the α,β-unsaturated carbonyl of SLs, our studies showed that less than 6 % of SLs
are bound to this position within 60 minutes. Thus, a reaction with other amino acids
as well as non-covalent interactions with plasma proteins have to be considered. Considering
the biological activity of SLs in whole blood, our studies demonstrate that knowledge
of their plasma protein binding is important for interpreting the reported data of
in vitro and ex vivo assays.
Key words
Arnica montana
-
Tanacetum parthenium
- Asteraceae - sesquiterpene lactone - protein binding - human serum albumin - plasma
- whole blood - bioavailability
References
1
Schmidt T J.
Toxic activities of sesquiterpene lactones: Structural and biochemical aspects.
Curr Org Chem.
1999;
3
577-608
2
Schmidt T J.
Helenanolide-type sesquiterpene lactones - III. Rates and stereochemistry in the reaction
of helenalin and related helenanolides with sulfhydryl containing biomolecules.
Bioorg Med Chem.
1997;
5
645-53
3
Ruengeler P, Castro V, Mora G, Goren N, Vichnewski W, Pahl H L. et al .
Inhibition of transcription factor NF-kappaB by sesquiterpene lactones: a proposed
molecular mechanism of action.
Bioorg Med Chem.
1999;
7
2343-52
4
Humar M, García-Pineres A J, Castro V, Merfort I.
Effect of sesquiterpene lactones on the expression of the activation marker CD69 and
of IL-2 in T-lymphocytes in whole blood.
Biochem Pharmacol.
2003;
65
1551-63
5
Grippo A A, Wyrick S D, Lee K H, Shrewsbury R P, Hall I H.
Disposition of an antineoplastic sesquiterpene lactone, [3
H ]-plenolin, in BDF1 mice.
Planta Med.
1991;
57
309-14
6
Hill D W, Bailey E M, Camp B J.
Tissue distribution and disposition of hymenoxon.
J Agric Food Chem.
1980;
28
1269-73
7
Knight D W.
Feverfew: chemistry and biological activity.
Nat Prod Rep.
1995;
12
271-6
8
Fischer N H, Lu T, Cantrell C L, Castaneda-Acosta J, Quijano L, Franzblau S G.
Antimycobacterial evaluation of germacranolides.
Phytochemistry.
1998;
49
559-64
9
Knuesel O, Weber M, Suter A.
Arnica montana gel in osteoarthritis of the knee: an open, multicenter clinical trial.
Adv Ther.
2002;
19
209-18
10 Willuhn G.
Arnica flowers: Pharmacology, toxicology and analytics of the sesquiterpene lactones - their
main active substances. In: Lawson LD, Bauer R (editors) Phytomedicines of Europe.
Washington: American Chemical Society 1996: p 118-32
11
Willuhn G, Leven W.
On the qualitative and quantitative analysis of the sesquiterpene lactones of Arnicae
flos DAB 9.
PZ (Pharmazeutische Zeitung) Wissenschaft.
1991;
136
32-9
12 Thomas L. Labor und Diagnose: Indikation und Bewertung von Laborbefunden für die
Medizinische Diagnostik. 5 ed Frankfurt/Main; TH-Books 1998
13
Ellman G L.
A colorimetric method for determining low concentrations of mercaptans.
Arch Biochem Biophys.
1958;
74
443-50
14
Peters T J r.
Serum albumin.
Adv Protein Chem.
1985;
37
161-245
15
Kratz F, Warnecke A, Scheuermann K, Stockmar C, Schwab J, Lazar P. et al .
Probing the cysteine-34 position of endogenous serum albumin with thiol-binding doxorubicin
derivatives. Improved efficacy of an acid-sensitive doxorubicin derivative with specific
albumin-binding properties compared to that of the parent compound.
J Med Chem.
2002;
45
5523-33
16
Schmidt T J, Lyss G, Pahl H L, Merfort I.
Helenanolide type sesquiterpene lactones. Part 5: the role of glutathione addition
under physiological conditions.
Bioorg Med Chem.
1999;
7
2849-55
17 Hausen B M, Vieluf I K. Allergiepflanzen, Pflanzenallergene. Landsberg, München;
Ecomed Verlagsgesellschaft 1997
18
Benard O, Balasubramanian K A.
Effect of oxidant exposure on thiol status in the intestinal mucosa.
Biochem Pharmacol.
1993;
45
2011-5
19
Adamowicz A, Trafikowska U, Trafikowska A, Zachara B, Manitius J.
Effect of erythropoietin therapy and selenium supplementation on selected antioxidant
parameters in blood of uremic patients on long-term hemodialysis.
Med Sci Monit.
2002;
8
202-5
20
Heptinstall S, Groenewegen W A, Spangenberg P, Loesche W.
Extracts of feverfew may inhibit platelet behaviour via neutralization of sulphydryl
groups.
J Pharm Pharmacol.
1987;
39
459-65
21
Franot C, Benezra C, Lepoittevin J P.
Synthesis and interaction studies of 13 C labeled lactone derivatives with a model protein using 13 C NMR.
Bioorg Med Chem.
1993;
1
389-97
Prof. Dr. I. Merfort
Institut für Pharmazeutische Wissenschaften
Lehrstuhl für Pharmazeutische Biologie
Universität Freiburg
Stefan-Meier-Str. 19
79104 Freiburg
Germany
Phone: +49-761-203-8373
Fax: +49-761-203-8383
Email: irmgard.merfort@pharmazie.uni-freiburg.de